Related Experiment Videos
Thrombosis, fibrinolysis, and thrombolytic therapy: a perspective
1Department of Medicine, Temple University School of Medicine, Philadelphia, PA 19140.
Progress in Cardiovascular Diseases
|September 1, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Accessible and reliable neurometric testing in humans using a smartphone platform.
Scientific reports·2023
Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
International angiology : a journal of the International Union of Angiology·2012
Safety of catheter-delivered plasmin in patients with acute lower extremity arterial or bypass graft occlusion: phase I results.
Journal of thrombosis and haemostasis : JTH·2012
Historical perspective and future direction of thrombolysis research: the re-discovery of plasmin.
Journal of thrombosis and haemostasis : JTH·2011
Anti-PF4/heparin antibody formation postorthopedic surgery thromboprophylaxis: the role of non-drug risk factors and evidence for a stoichiometry-based model of immunization.
Journal of thrombosis and haemostasis : JTH·2010
Joint associations of Interleukin-6 and apolipoprotein B with major adverse cardiovascular events in the UK biobank.
Progress in cardiovascular diseases·2026
Obesity, lipids, inflammation, and healthy aging.
Progress in cardiovascular diseases·2026
Revascularization options for managing patients with multi-vessel coronary artery disease.
Progress in cardiovascular diseases·2026
Transcatheter versus surgical pulmonary valve replacement in native RVOT: A 3-year propensity score-matched study.
Progress in cardiovascular diseases·2026
Large language models in sports cardiology: Challenges, governance, and human-in-the-loop integration.
Progress in cardiovascular diseases·2026
Does Tranexamic acid fix all bleeding in surgery?
Journal of the National Medical Association·2026
Pharmacokinetics, Elimination and Dialyzability of HRS-9231 in Patients with Varying Degrees of Renal Impairment.
Clinical pharmacokinetics·2026